13‑Panel Multi-Drug Rapid Urine Test Cup (incl. Fentanyl + PCP) - FDA 510(k) Cleared - 100/Case

The 13‑Panel Rapid Urine Test Cup (incl. Fentanyl + PCP) provides comprehensive screening for 13 substances, including an ultra‑sensitive fentanyl (FYL) panel at 1 ng/mL and PCP at 25 ng/mL. Each kit contains 100 individually sealed cups with integrated 3 mm collection chambers, designed for professional laboratory and clinical settings. Built‑in reagents produce clear, visible results within minutes, eliminating the need for separate testing equipment. The standardized 3 mm depth ensures consistent sample collection and accurate detection across all tested compounds. Ideal for workplace compliance programs, medical facilities, and substance‑use monitoring, this test cup combines ease of use with dependable performance for high‑volume screening.

FDA 510(k) cleared panels; distributed by an FDA‑registered medical distributor. For professional in vitro diagnostic screening use only. All positive results are presumptive and should be confirmed using a laboratory method such as GC/MS or LC‑MS/MS. CLIA‑waived status, where applicable, varies by configuration; consult product labeling. Store at room temperature per packaging instructions.

What’s Included:

• 100 x Multi‑Drug Rapid Urine Test Cups (individually pouched)
• Instructions for use (IFU)

How to Use:

• Collect urine directly into the cup to the indicated fill line.
• Secure the lid and activate per IFU.
• Read results within the specified time window; do not interpret after the maximum read time.
• Video instructions: https://www.youtube.com/watch?v=4zRgq1UGkZI

Key Features:

    FDA 510(k) cleared panels; distributed by an FDA‑registered medical distributor
    Includes Fentanyl (FYL) panel at 1 ng/mL sensitivity and PCP at 25 ng/mL
    Integrated cup with built‑in reagents — no separate analyzer required
    Standardized 3 mm collection chamber for consistent sampling
    Clear, visible results within minutes
    100 individually sealed cups per case — ideal for high‑volume screening
    For professional use in clinical, laboratory, and workplace compliance programs
    Presumptive screening only; confirm positives by GC/MS or LC‑MS/MS

Drugs Detected:

    AMP at 500 ng/mL (Amphetamines)
    BAR at 300 ng/mL (Barbiturates)
    BUP at 10 ng/mL (Buprenorphine)
    BZO at 300 ng/mL (Benzodiazepines)
    COC at 150 ng/mL (Cocaine)
    MDMA at 500 ng/mL (Ecstasy)
    MET at 500 ng/mL (Methamphetamine)
    MTD at 300 ng/mL (Methadone)
    OPI at 300 ng/mL (Opiates; Morphine/Codeine class)
    OXY at 100 ng/mL (Oxycodone)
    PCP at 25 ng/mL (Phencyclidine)
    THC at 50 ng/mL (Marijuana)
    FYL at 1 ng/mL (Fentanyl)